Clinical trial
An Open-label, PRospective Study to Evaluate Social Function and Overall Improvement of Paliperidone ER Treatment in Thai Schizophrenia PatieNT (PRESENT)
NCT01387542 is registered in ClinicalTrials.gov with Janssen-Cilag Ltd.,Thailand as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-label, PRospective Study to Evaluate Social Function and Overall Improvement of Paliperidone ER Treatment in Thai Schizophrenia PatieNT (PRESENT)
- Lead sponsor
- Janssen-Cilag Ltd.,Thailand
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- August 31, 2009
- Completion date
- September 30, 2010
- Enrollment
- 40 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.